Safety and Efficacy of J147 in Acute Ischemic Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marguerite Prior, Ph.D.
Abrexa Pharmaceuticals, Inc.
Study Director - Steven J Warach, MD, PhD
Dell Seton Medical Center at the University of Texas at Austin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dell Seton Medical Center at the University of Texas at Austin
Austin, Texas, United States
Borna Tabibian, MDElham Askari, MDHamidreza Saber, MDJefferson Miley, MDLisa Davis, PhD, RNManzure Mawla, DOMatthew Padrick, MDRachel Pearson, MDSteven J Warach, MD, PhDSupreet Kaur, MDZachary Brittingham, DO
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2026
- Primary completion
- 1 Mar 2028
- Completion
- 1 Jul 2028
- Last update posted
- 7 Apr 2026
- Registered enrollment
- 196
- Registry id
- NCT07430917
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.